Investor Relations

Focused on enhancing shareholder value through creating and delivering meaningful advancements in early intervention orthopedic care.
Stock quote is delayed by 15 minutes
NASDAQANIK
Woman throwing punch at punching bag.

Investor Relations

Focused on enhancing shareholder value through creating and delivering meaningful advancements in early intervention orthopedic care.
Stock quote is delayed by 15 minutes
NASDAQANIK
Financial and Operational Metrics

(As of December 31, 2022)

  • $156M

    FY’22 Revenue

    6% YtY Growth

  • 11%

    Revenue CAGR

    FY’19 – FY’22

  • #1

    U.S. Market Share

    OA Pain Management

  • $86M

    Cash balance
    with no debt

Recent News
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
Mar 15, 2023

BEDFORD, Mass. — March 15, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
Mar 8, 2023

BEDFORD, Mass., March 8, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it is highlighting recently-launched products in high growth segments...

Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
Mar 6, 2023

BEDFORD, Mass., March 6, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth...

All Press Releases

Current Investor Presentation

View PresentationView More
Investor Day 2021

View Presentation

Investor Contacts

Primary IR Contact

  • Mark Namaroff

    Vice President, Investor Relations, ESG, and Corporate Communications

    Anika Therapeutics, Inc.

    Phone: (781) 457-9287

    Email: investorrelations@anika.com

  • Transfer Agent

    American Stock Transfer & Trust Co.

    59 Maiden Lane

    New York, NY 10038

    Phone: (718) 921-8261

Want Alerts? Sign up for alerts and never miss an Investor update!

Subscribe

To Top